[1] Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci, 1982; 389, 406−8. doi:  10.1111/j.1749-6632.1982.tb22153.x
[2] Verma S, Szmitko PE, Ridker PM. C-reactive protein comes of age. Nat Clin Pract Cardiovasc Med, 2005; 2, 29−36. doi:  10.1038/ncpcardio0074
[3] Waliza A, Shymasree G. C-reactive protein and the biology of disease. Immunol Res, 2013; 56, 131−42. doi:  10.1007/s12026-013-8384-0
[4] Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med, 1930; 52, 561−71. doi:  10.1084/jem.52.4.561
[5] Wang ZW, Wang X, Chen Z, et al. Distribution of high-sensitivity C-reactive protein and its relationship with other cardiovascular risk factors in the middle-age Chinese population. Int J Environ Res Public Health, 2016; 13, 872. doi:  10.3390/ijerph13090872
[6] Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest, 2003; 111, 1805−12. doi:  10.1172/JCI200318921
[7] Salazar J, Martinez MS, Chavez M, et al. C-reactive protein: clinical and epidemiological perspectives. Cardiol Res Pract, 2014; 56, 131−42.
[8] Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res, 2013; 48, 155−70.
[9] Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med, 1999; 17, 1019−25. doi:  10.1016/S0736-4679(99)00135-3
[10] Das T, Sen A, Kempf T, et al. Induction of glycosylation in human C-reactive protein under different pathological conditions. Biochem J, 2003; 373, 345−55. doi:  10.1042/bj20021701
[11] Yi P. Comparison of the results of two methods in detecting CRP and hsCRP. Acta Medicinae Sinica, 2015; 28, 95−8.
[12] Yu H, Rifai N. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin Biochem, 2000; 8, 601−10.
[13] Allin KH, Nordestgaard BG. Elevated C-reactive protein in diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci, 2011; 26, 209−15.
[14] Yang LF, Chen AH, Gu CB, et al. Clinical value of serum highsensitive C-reactive protein detection in patients with unstable angina pectoris. Appl J General Pract, 2007; 5, 798−9. (In Chinese)
[15] Wu ZT, Li L, Ma ZZ, et al. The changes and the clinical significance of CRP level in serum in CHF. Chinese Journal of General Practice, 2010; 18, 1403−4. (In Chinese)
[16] Li XJ, Wang YN, Fan X, et al. High-sensitivety c-reactive protein and its clinical significance in cardiovascular diseases. Adv Cardiovase Dis, 2007; 28, 92−6.
[17] Zhang XH, Li GT, Zhang ZL. Clinical Significances of C-reactive protein and hypersensitive C-reactive protein. Chin J Aller Clini Immunol, 2011; 5, 74−9. (In Chinese)
[18] Hung J, Knuiman MW, Divitini ML, et al. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Am J Cardiol, 2008; 101, 193−8. doi:  10.1016/j.amjcard.2007.07.061
[19] McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care, 2009; 12, 223−6. doi:  10.1097/MCO.0b013e32832a7902
[20] Khera A, McGuire DK, Murphy SA, et al. Race and gender different in C-reactive protein levels. J Am Coll Cardiol, 2005; 46, 464−9. doi:  10.1016/j.jacc.2005.04.051
[21] Lin GM, Liu K, Colangel LA, et al. Low-density lipoprotein cholesterol concentrations and association of high-sensitivity C-reactive protein concentration with incident coronary heart disease in the multi-ethnic study of atheroscerosis. Am J Epidemiol, 2016; 183, 46−52. doi:  10.1093/aje/kwv144
[22] Zhao YF, Wang R, Ma XQ, et al. Distribution of C-reactive protein and its association with cardiovascular risk factors in a population-based sample of Chinese. Dis Markers, 2010; 28, 333−42. doi:  10.1155/2010/270126
[23] Sung KC, Ryu S, Chang Y, et al. C-reactive protein and risk of cardiovascular and all-cause mortality in 268803 East Asians. Eur Heart J, 2014; 35, 1809−16. doi:  10.1093/eurheartj/ehu059
[24] Wang LJ, Huang J, Li H, et al. Distribution of iron status among urban Chinese women. Asia Pac J Clin Nutr, 2016; 25, 150−7.
[25] National Center for Health Statistics. National Health and Nutrition Examination Survey 2005-2006. Documentation, codebook, and frequencies. Laboratory component. 2008/4 [cited 2014/2]; http://www.cdc.gov/nchs/nhanes/nhanes/2005-2006/FERTIN_D.htm.
[26] Sisman AR, Kume T, Tas G, et al. Comparison and evaluation of two C-reactive protein assays based on particle-enhanced immunoturbidimetry. J Clin Lab Anal, 2007; 21, 71−6. doi:  10.1002/jcla.20141
[27] Tang XF, Lin TS, Zhao ZH, et al. Distribution and analysis of trace CRP in blood of 492 healthy people. Shanghai J of Med Lab Sci, 2003; 18, 314−6. (In Chinese)
[28] Dong Q, Yang D, Ye H, et al. Distributions of C-reactive protein and association with lipid in 579 healthy volunteers. Clin J Hemor, 2006; 26, 444−6. (In Chinese)
[29] Yuan BJ, Zhang HF, Zou JM, et al. Distribution of C-reactive protein in healthy adult serum. Chin J Clin Lab Sci, 2005; 23, 236−7. (In Chinese)
[30] Song HW. Expression of serum high sensitive C reactive protein in high LDL-C patient. Chin J Med Writ, 2004; 11, 561−2. (In Chinese)
[31] Choi EY, Park EH, Cheong YS, et al. Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans. Metabolism, 2006; 55, 415−21. doi:  10.1016/j.metabol.2005.11.002
[32] Ford ES, Giles WH, Mokdad AH, et al. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem, 2004; 50, 574−81. doi:  10.1373/clinchem.2003.027359
[33] Hwang HS, Kwon JY, Kim MA, et al. Maternal serum highly sensitive C-reactive protein in normal pregnancy and preeclampsia. Int J Gynaecol Obstet, 2007; 98, 105−9. doi:  10.1016/j.ijgo.2007.03.050
[34] Belo L, Santos-Silva A, Rocha S, et al. Pereira-Leite L. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol, 2005; 123, 46−51. doi:  10.1016/j.ejogrb.2005.02.022
[35] Wang LR. Relationship between serum C-reactive protein level and gestational diabetes mellitus. J Clin Pathol Res, 2016; 36, 924−8.
[36] Tian M, Wu LF. Analysis on the clinical characteristics of pregnant women with gestational diabetes mellitus combined with hypertensive disorder complicating pregnancy and serum levels of C-reactive protein interleukin-6 and tumor necrosis factor-α. Maternal and Child Health Care of China, 2012; 27, 1318−21. (In Chinese)
[37] de Ferranti S, Rifai N. C-reactive protein and cardiovascular disease: a review of risk prediction and intervenetions. Clin Chim Acta, 2002; 317, 1−15. doi:  10.1016/S0009-8981(01)00797-5
[38] Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American college of on practice guidelins. J Am Coll Cardiol, 2010; 56, e50−e103. doi:  10.1016/j.jacc.2010.09.001